You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Squamous Cell Carcinoma of Head and Neck

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Head and Neck Squamous Cell Carcinoma, PET/CT Trial (Neck dissection)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • PET/CT
  • Neck dissection
  • (no location specified)
Jan 31, 2023

Locally Advanced Head and Neck Squamous Cell Carcinoma Trial (Toripalimab)

Not yet recruiting
  • Locally Advanced Head and Neck Squamous Cell Carcinoma
  • (no location specified)
Mar 20, 2023

Head and Neck Squamous Cell Carcinoma Trial (Carrilizumab, bevacizumab,capecitabine)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Carrilizumab, bevacizumab,capecitabine
  • (no location specified)
Jul 20, 2023

Squamous Cell Carcinoma of the Head and Neck (SCCHN), Recurrent Squamous Cell Carcinoma of the Head and Neck, Metastatic Head

Recruiting
  • Squamous Cell Carcinoma of the Head and Neck (SCCHN)
  • +4 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 19, 2023

Head and Neck Squamous Cell Carcinoma, Head Neck Cancer Trial (Tislelizumab, BGB-A425, LBL-007)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Head and Neck Cancer
  • (no location specified)
Jun 9, 2023

Neoadjuvant Therapy for Head and Neck Squamous Cell Carcinoma

Recruiting
  • Head and Neck Squamous Cell Carcinoma
    • Hangzhou, Zhejiang, China
      Second Affiliated Hospital, School of Medicine, Zhejiang Univers
    Aug 22, 2023

    Needs and Preferences of Patients With Head-neck Cutaneous SCC

    Active, not recruiting
    • Cutaneous Squamous Cell Carcinoma
    • +10 more
    • Regular care with additional administration of a semi-structured interview
    • Maastricht, Netherlands
      Maastricht University Medical Center+
    Sep 13, 2023

    Head and Neck Squamous Cell Carcinoma Trial (HS-20093)

    Not yet recruiting
    • Head and Neck Squamous Cell Carcinoma
    • (no location specified)
    Aug 17, 2023

    Following Salvage Surgery for RESidual or reCurrent sqUamous

    Not yet recruiting
    • Head and Neck Cancer
    • Molecular Analyses
    • (no location specified)
    Mar 28, 2023

    Head and Neck Squamous Cell Carcinoma Trial in Guangzhou (Nab paclitaxel, Carboplatin, adelbelimumab)

    Not yet recruiting
    • Head and Neck Squamous Cell Carcinoma
    • Nab paclitaxel
    • +2 more
    • Guangzhou, Guangdong, China
      Sun Yat-sen Memorial Hospital
    Aug 24, 2023

    Head and Neck Squamous Cell Carcinoma, Locally Advanced Operable Trial in Guangzhou (Cadonilimab, Docetaxel, Cisplatin)

    Recruiting
    • Head and Neck Squamous Cell Carcinoma
    • Locally Advanced Operable
    • Guangzhou, Guangdong, China
    • +1 more
    Sep 4, 2023

    Acupuncture on Acute Dysphagia in Patients Treated With

    Recruiting
    • Head and Neck Squamous Cell Carcinoma
      • Florence, Italy
      • +1 more
      Nov 6, 2022

      Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Squamous Cell Carcinoma, Stage IV Cutaneous Squamous Cell

      Not yet recruiting
      • Head and Neck Squamous Cell Carcinoma
      • +2 more
      • Panitumumab
      • +4 more
      • Nashville, Tennessee
        Vanderbilt University/Ingram Cancer Center
      Feb 16, 2023

      Prognostic Immune Biomarkers in HNSCC

      Completed
      • Head and Neck Cancer
      • Squamous Cell Carcinoma
      • Tumour immunoprofile evaluation
      • Ostrava, Moravian-Silesian Region, Czechia
        University Hospital Ostrava
      Jul 3, 2023

      Head and Neck Carcinoma Trial in Cairo (Elective nodal de-escalation arm)

      Recruiting
      • Head and Neck Carcinoma
      • Elective nodal de-escalation arm
      • Cairo, Egypt
        National Cancer Institute
      Dec 6, 2022

      Locally Advanced Head and Neck Squamous Cell Carcinoma Trial in Tianjin (Toripalimab, Stereotactic Body Radiation Therapy

      Not yet recruiting
      • Locally Advanced Head and Neck Squamous Cell Carcinoma
      • Tianjin, China
      • +1 more
      May 16, 2023

      Disease-free Survival of High-risk Head-neck Cutaneous Squamous

      Active, not recruiting
      • Carcinoma, Squamous Cell
      • +5 more
      • Treatment
      • Maastricht, Netherlands
      • +1 more
      Apr 26, 2023

      Head and Neck Squamous Cell Carcinoma, Head Neck Cancer, Resectable Head and Neck Squamous Cell Carcinoma Trial in Boston

      Not yet recruiting
      • Head and Neck Squamous Cell Carcinoma
      • +3 more
      • Boston, Massachusetts
      • +1 more
      Feb 11, 2023

      Cancer of Head and Neck, Head Neck Cancer, Tumors, Head and Neck Trial in Boston, Saint Louis, New York (biological, procedure,

      Active, not recruiting
      • Cancer of Head and Neck
      • +5 more
      • MK-3475 (neoadjuvant)
      • +6 more
      • Boston, Massachusetts
      • +2 more
      Dec 9, 2022

      Head and Neck Squamous Cell Cancer

      Recruiting
      • Head and Neck Squamous Cell Carcinoma
      • OncoPrism-HNSCC™
      • San Francisco, California
        Curebase
      Sep 7, 2022

      Metastatic Melanoma, Head and Neck Squamous Cell Carcinoma Trial in Portland (GB1211, Pembrolizumab, Placebo)

      Not yet recruiting
      • Metastatic Melanoma
      • Head and Neck Squamous Cell Carcinoma
      • Portland, Oregon
        Providence Portland Medical Center
      Jun 19, 2023

      Recurrent Head Neck Cancer, Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Carcinoma Trial in Saint

      Not yet recruiting
      • Recurrent Head and Neck Cancer
      • +5 more
      • Saint Louis, Missouri
        Washington University School of Medicine
      Jul 30, 2023

      Oligometastatic Squamous Cell Carcinoma of the Head and Neck Trial (Pembrolizumab, stereotattic ablation radiotherapy (SABR))

      Not yet recruiting
      • Oligometastatic Squamous Cell Carcinoma of the Head and Neck
      • (no location specified)
      Apr 14, 2023

      Head and Neck Squamous Cell Carcinomas Trial (Tislelizumab + Dasatinib + Quercetin, surgery)

      Not yet recruiting
      • Head and Neck Squamous Cell Carcinomas
      • Tislelizumab + Dasatinib + Quercetin
      • surgery
      • (no location specified)
      Feb 2, 2023

      Squamous Cell Carcinoma of the Oral Cavity, Squamous Cell Carcinoma of the Larynx, Squamous Cell Carcinoma of the Hypopharynx

      Not yet recruiting
      • Squamous Cell Carcinoma of the Oral Cavity
      • +3 more
      • Eliminating RT to the elective neck
      • RT standard of care
      • Erlangen, Bavaria, Germany
        Universitätsklinikum Erlangen, Strahlenklinik
      Sep 8, 2023